» Articles » PMID: 33511075

Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine

Overview
Specialty Gastroenterology
Date 2021 Jan 29
PMID 33511075
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) accounts for hepatitis, liver cirrhosis, hepatocellular carcinoma, and liver transplantation. This virus is a single-stranded RNA virus that belongs to the Flaviviridae family. According to the WHO, about 71 million people have chronic HCV infections around the globe in 2020, and hence, it is a plague of humankind. The credit of discovery of HCV goes to Michael Houghton, Harvey Alter, and Charles Rice for which they are awarded 2020 Nobel Prize in Medicine. Their contribution has given better hope to mankind to cure HCV for the first time in the history. With the use of pegylated interferon and ribavirin jointly, higher SVR has been found comparatively, even in patients with chronic liver diseases. However, due to excessive pain tolerated by patients, interferon (IFN)-based therapy is rapidly being replaced with IFN-free DAA regimens. With the onset of resistance to DAA drugs, CRISPR-Cas system can be used to modify the viral genome to impair their ability to develop resistance. Laugi H. Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine. Euroasian J Hepato-Gastroenterol 2020;10(2): 105-108.

Citing Articles

Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions.

Dunn K, Biondi M, Lee S Microorganisms. 2024; 12(11).

PMID: 39597752 PMC: 11596142. DOI: 10.3390/microorganisms12112364.


Revolution in the diagnosis and management of hepatitis C virus infection in current era.

Hanif F, Majid Z, Hassan Luck N, Tasneem A, Laeeq S, Mubarak M World J Hepatol. 2022; 14(4):647-669.

PMID: 35646260 PMC: 9099099. DOI: 10.4254/wjh.v14.i4.647.


E-cadherin and aquaporin 1 co-expression analysis in hepatocellular carcinoma: a pilot study.

Ciurea A, Vere C, Popp C, Streba C, Calita M, Pirici D Rom J Morphol Embryol. 2022; 62(2):427-434.

PMID: 35024730 PMC: 8848220. DOI: 10.47162/RJME.62.2.08.

References
1.
Gressner O, Weiskirchen R, Gressner A . Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med. 2007; 11(5):1031-51. PMC: 4401271. DOI: 10.1111/j.1582-4934.2007.00092.x. View

2.
Vermehren J, Park J, Jacobson I, Zeuzem S . Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection. J Hepatol. 2018; 69(5):1178-1187. DOI: 10.1016/j.jhep.2018.07.002. View

3.
Lohmann V, KORNER F, Koch J, Herian U, Theilmann L, Bartenschlager R . Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999; 285(5424):110-3. DOI: 10.1126/science.285.5424.110. View

4.
Feinstone S, Kapikian A, Purceli R . Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973; 182(4116):1026-8. DOI: 10.1126/science.182.4116.1026. View

5.
Valva P, Rios D, De Matteo E, Preciado M . Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol. 2016; 22(4):1367-81. PMC: 4721972. DOI: 10.3748/wjg.v22.i4.1367. View